bpc-157 human clinical trial randomized controlled Sequential biopharmaceutical and regulatory barriers limiting BPC-157 – No Proof Required!

Mild cognitive issues in children and teenagers aged 7-18: A dose of 200400mcg, split into two daily doses, for 30-days

Seizures are controlled by antiseizure medications in about half of patients and disappear after biotin administration, while in patients who do not receive antiseizure medications, most seizures stop within 24 hours of starting biotin application

These results therefore provide evidence that the degenerated retina maintains some ultrasound sensitivity, enabling RGC activity modulation and the consecutive stimulation of higher visual areas for visual restoration

Furthermore, it discusses the challenges in clinical translation and outlines future research directions